Cambrex Corporation has announced its acquirement of PharmaCore for a purchase consideration of $25 million.
Wombat Capital Markets is acting as advisor to PharmaCore for the acquisition, which is expected to be completed by October 2016.
Go deeper with GlobalData
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
The acquisition will enable Cambrex to expand its product portfolio in the US and European markets.
Sichuan Kelun Pharmaceutical has announced it will acquire an 80% stake in an unrevealed biotechnology company.
The company expects that the acquisition will cost them up to $9.59 million.
US Tariffs are shifting - will you react or anticipate?
Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.
By GlobalData
